Development of a HA1-specific enzyme-linked immunosorbent assay against pandemic influenza virus A H1N1

다국어 초록 (Multilingual Abstract)

Purpose: Enzyme-linked immunosorbent assay (ELISA) has been used in the diverse field to evaluate influenza virus infection; for the surveillance, diagnosis, efficacy evaluation, and development of the vaccine. The aim of this study was to establish an ELISA for detecting HA strain-specific antibodies using recombinant pandemic A H1N1 (pH1N1) HA1 (rHA1) protein.
Materials and Methods: rHA1 was produced in baculovirus system. The clinical performance of the developed ELISA was validated using human serum samples, by comparison with standard methods for detecting a neutralizing antibody; hemagglutination inhibition (HI) assay and microneutralization test (MNT). The ability of the ELISA system to evaluate the efficacy test of an influenza vaccine was explored by measuring antibody levels in the serum of vaccinated mice.
Results: Our ELISA could detect anti-rHA1 antibody in influenza-infected patients and vaccinated subjects. Compared to HI assay and MNT as reference methods, our method showed good performance in detection of anti-rHA1 antibody. Detection of the anti-rHA1 antibody in vaccinated mice and its correlation with titers in HI assay was also proved in a mice model.
Conclusion: An ELISA system using rHA1 of pH1N1 influenza virus was developed, and showed good clinical performance in diagnosis of influenza virus infection and evaluation of the vaccination efficacy in both human and animal models.

참고문헌 (Reference)

1 Ward BJ, "The establishment of surrogates and correlates of protection: useful tools for the licensure of effective influenza vaccines?" 14 : 647-656, 2018

2 Alvarez MM, "Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method" 5 : e10176-, 2010

3 Katz JM, "Serologic assays for influenza surveillance, diagnosis and vaccine evaluation" 9 : 669-683, 2011

4 Moon SJ, "Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients" 13 : 165-, 2012

5 Centers for Disease Contorl and Prevention, "H1N1 flu" 29 : 271-278, 2009

6 Vemula SV, "Current approaches for diagnosis of influenza virus infections in humans" 8 : 96-, 2016

7 Grund S, "Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus" 171 : 369-373, 2011

8 Garten RJ, "Antigenic and genetic characteristics of swine-origin 2009 A(H1N1)influenza viruses circulating in humans" 325 : 197-201, 2009